AFL logo

AFLAC Incorporated (AFL)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

AFLAC Incorporated (AFL) trades at $106.23 with AI Score 40/100 (Weak). Aflac Incorporated is a leading provider of supplemental health and life insurance, operating primarily in the U. S. and Japan. Market cap: 55B, Sector: Financial services.

Last analyzed: Feb 8, 2026
Aflac Incorporated is a leading provider of supplemental health and life insurance, operating primarily in the U.S. and Japan. The company distinguishes itself through its strong brand recognition and focus on specialized insurance products.
40/100 AI Score Target $109.00 (+2.6%) MCap 55B Vol 605K

AFLAC Incorporated (AFL) Financial Services Profile

CEODaniel Paul Amos
Employees12694
HeadquartersColumbus, GA, US
IPO Year1980

Aflac, a stalwart in supplemental insurance, offers a notable research candidate driven by its dominant market share in Japan and a growing presence in the U.S., underpinned by a robust profit margin of 23.2% and a consistent dividend yield of 1.98% for long-term value creation.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Aflac presents a notable research candidate due to its established market leadership in Japan and its growing presence in the U.S. The company's strong brand recognition, coupled with its focus on supplemental insurance products, provides a competitive edge. With a P/E ratio of 14.89 and a healthy profit margin of 23.2%, Aflac demonstrates financial stability and profitability. The dividend yield of 1.98% offers investors a steady income stream. Key value drivers include continued growth in the U.S. market, driven by increasing awareness of the need for supplemental insurance, and the ability to maintain its dominant position in Japan. Upcoming catalysts include new product launches and strategic partnerships to expand its distribution network. Aflac's low beta of 0.66 suggests lower volatility compared to the overall market, making it a noteworthy option for risk-averse investors.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $61.40 billion, reflecting significant investor confidence in Aflac's market position and future prospects.
  • Profit margin of 23.2%, indicating strong operational efficiency and pricing power within the supplemental insurance market.
  • Gross margin of 35.1%, showcasing effective cost management and the value proposition of Aflac's insurance products.
  • Dividend yield of 1.98%, providing a consistent return to shareholders and highlighting Aflac's commitment to returning value.
  • Beta of 0.66, suggesting lower volatility compared to the overall market, making it a relatively stable investment option.

Competitors & Peers

Strengths

  • Strong brand recognition, especially in Japan.
  • Extensive distribution network.
  • Focus on supplemental insurance.
  • Healthy profit margin of 23.2%.

Weaknesses

  • Reliance on the Japanese market.
  • Exposure to regulatory changes in the insurance industry.
  • Potential impact from economic downturns.
  • Competition from larger, more diversified insurance companies.

Catalysts

  • Upcoming: New product launches in the U.S. market to cater to evolving customer needs.
  • Ongoing: Expansion of the distribution network through strategic partnerships.
  • Ongoing: Digital transformation initiatives to enhance customer experience and improve efficiency.
  • Ongoing: Continued growth in the U.S. supplemental insurance market.
  • Ongoing: Maintenance of market leadership in Japan.

Risks

  • Potential: Increasing healthcare costs could impact profitability.
  • Potential: Changes in consumer preferences could affect demand for supplemental insurance.
  • Ongoing: Regulatory scrutiny could lead to increased compliance costs.
  • Potential: Economic downturns could reduce consumer spending on insurance products.
  • Ongoing: Competition from other insurance companies could erode market share.

Growth Opportunities

  • Expansion in the U.S. Market: Aflac has a significant opportunity to expand its presence in the U.S. market by increasing awareness of its supplemental insurance products. The U.S. supplemental health insurance market is estimated to be worth billions of dollars, and Aflac can capitalize on this growth by targeting specific demographics and offering tailored insurance solutions. Timeline: Ongoing, with continuous marketing and sales efforts.
  • New Product Development: Aflac can drive growth by developing and launching new insurance products that cater to emerging customer needs. This includes products focused on telehealth, mental health, and other specialized areas. By innovating and expanding its product portfolio, Aflac can attract new customers and increase revenue. Timeline: Ongoing, with continuous market research and product development.
  • Strategic Partnerships: Aflac can leverage strategic partnerships to expand its distribution network and reach new customer segments. This includes partnerships with healthcare providers, employers, and other organizations. By collaborating with key players in the healthcare ecosystem, Aflac can increase its market reach and drive sales. Timeline: Ongoing, with continuous partnership exploration and development.
  • Digital Transformation: Aflac can enhance its customer experience and improve operational efficiency through digital transformation initiatives. This includes investing in online platforms, mobile apps, and data analytics. By embracing digital technologies, Aflac can streamline its processes, reduce costs, and provide a more seamless experience for its customers. Timeline: Ongoing, with continuous investment in digital infrastructure and capabilities.
  • Geographic Expansion: While Aflac has a strong presence in Japan and the U.S., it can explore opportunities to expand into new geographic markets. This includes countries with growing economies and increasing demand for insurance products. By diversifying its geographic footprint, Aflac can reduce its reliance on existing markets and drive long-term growth. Timeline: Potential, with continuous market analysis and strategic planning.

Opportunities

  • Expansion in the U.S. market.
  • New product development.
  • Strategic partnerships.
  • Digital transformation.

Threats

  • Increasing healthcare costs.
  • Changes in consumer preferences.
  • Regulatory scrutiny.
  • Economic recession.

Competitive Advantages

  • Strong brand recognition, particularly in Japan, provides a competitive advantage.
  • Extensive distribution network through sales associates, brokers, and agencies.
  • Focus on supplemental insurance products creates a niche market position.
  • Large and stable customer base provides recurring revenue.
  • Significant investment portfolio generates investment income.

About AFL

Aflac Incorporated, founded in 1955 and headquartered in Columbus, Georgia, has evolved into a Fortune 500 company and a leading provider of supplemental health and life insurance. The company operates through two principal segments: Aflac Japan and Aflac U.S. Aflac Japan offers a suite of insurance products tailored to the Japanese market, including cancer insurance, medical insurance, nursing care income support, GIFT, and both whole and term life insurance policies. They also provide saving-type insurance products like WAYS and child endowment plans. This segment has been a cornerstone of Aflac's success, capitalizing on the unique needs and preferences of Japanese consumers. In the United States, Aflac U.S. provides a range of supplemental insurance products, including cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance. These products are designed to complement primary insurance coverage, providing financial protection against unexpected health-related expenses. Aflac distributes its products through a multi-channel approach, leveraging sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. This diversified distribution network allows Aflac to reach a broad customer base and maintain a strong market presence in both the U.S. and Japan. With a workforce of 12,694 employees, Aflac continues to innovate and adapt to the evolving needs of its customers, solidifying its position as a leader in the supplemental insurance market.

What They Do

  • Provides supplemental health insurance in the United States.
  • Offers life insurance products in the United States.
  • Provides cancer insurance in Japan.
  • Offers medical insurance in Japan.
  • Provides nursing care income support insurance in Japan.
  • Sells savings-type insurance products in Japan, including endowment plans.
  • Distributes insurance products through sales associates and brokers.
  • Operates through Aflac Japan and Aflac U.S. segments.

Business Model

  • Aflac generates revenue by selling supplemental health and life insurance policies.
  • Premiums are collected from policyholders in exchange for coverage.
  • Investment income is generated from the company's investment portfolio.
  • Profit is derived from the difference between premiums collected and claims paid, plus investment income.

Industry Context

Aflac operates within the insurance industry, specifically focusing on the supplemental health and life insurance market. This market is driven by increasing healthcare costs and a growing awareness of the need for financial protection against unexpected medical expenses. The competitive landscape includes established players like Berkshire Hathaway (BHF), CNO Financial Group (CNO), Fidelity & Guaranty Life (FG), Jackson Financial (JXN), and Lincoln National Corporation (LNC). Aflac differentiates itself through its strong brand recognition, particularly in Japan, and its focus on specialized insurance products. The industry is expected to continue growing, driven by demographic trends and increasing demand for supplemental coverage.

Key Customers

  • Individuals seeking supplemental health insurance coverage in the U.S.
  • Families seeking life insurance protection in the U.S.
  • Individuals seeking cancer and medical insurance in Japan.
  • Corporations offering supplemental insurance benefits to their employees in the U.S.
  • Individuals seeking nursing care income support in Japan.
AI Confidence: 73% Updated: Feb 8, 2026

Financials

Chart & Info

AFLAC Incorporated (AFL) stock price: $106.23 (-0.42, -0.39%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AFL.

Price Targets

Consensus target: $109.00

MoonshotScore

40/100

What does this score mean?

The MoonshotScore rates AFL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Latest AFLAC Incorporated Analysis

What Investors Ask About AFLAC Incorporated (AFL)

What does Aflac Incorporated do?

Aflac Incorporated is a leading provider of supplemental health and life insurance, operating primarily in the U.S. and Japan. The company offers a range of insurance products designed to complement primary insurance coverage, providing financial protection against unexpected health-related expenses. In Japan, Aflac focuses on cancer, medical, and nursing care income support insurance, while in the U.S., it offers cancer, accident, short-term disability, and other supplemental health insurance products. Aflac distributes its products through a multi-channel approach, leveraging sales associates, brokers, and agencies to reach a broad customer base.

Is AFL stock worth researching?

AFL stock presents a potentially attractive investment opportunity, supported by its strong market position, consistent profitability, and commitment to returning value to shareholders. With a P/E ratio of 14.89 and a dividend yield of 1.98%, Aflac demonstrates financial stability and offers a steady income stream. The company's growth potential in the U.S. market, coupled with its dominant position in Japan, provides a solid foundation for future growth. However, investors may want to evaluate the potential risks, including increasing healthcare costs and regulatory changes, before making an investment decision. Overall, AFL stock appears to be a reasonable investment for long-term investors.

What are the main risks for AFL?

Aflac faces several risks that could impact its financial performance and market valuation. Increasing healthcare costs could put pressure on profitability, as the company may need to increase premiums or absorb higher claims costs. Changes in consumer preferences could affect demand for supplemental insurance products, requiring Aflac to adapt its product offerings and marketing strategies. Regulatory scrutiny could lead to increased compliance costs and potential legal liabilities. Economic downturns could reduce consumer spending on insurance products, impacting Aflac's revenue and earnings. Competition from other insurance companies could erode market share, requiring Aflac to invest in marketing and product development to maintain its competitive edge.

What are the key factors to evaluate for AFL?

AFLAC Incorporated (AFL) currently holds an AI score of 40/100, indicating low score. The stock trades at a P/E of 15.4x, below the S&P 500 average (~20-25x), potentially signaling value. Analysts target $109.00 (+3% from $106.23). Key strength: Strong brand recognition, especially in Japan.. Primary risk to monitor: Potential: Increasing healthcare costs could impact profitability.. This is not financial advice.

How frequently does AFL data refresh on this page?

AFL prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AFL's recent stock price performance?

Recent price movement in AFLAC Incorporated (AFL) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $109.00 implies 3% upside from here. Notable catalyst: Strong brand recognition, especially in Japan.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider AFL overvalued or undervalued right now?

Determining whether AFLAC Incorporated (AFL) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 15.4. Analysts target $109.00 (+3% from current price), suggesting analysts see the stock near fair value. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying AFL?

Before investing in AFLAC Incorporated (AFL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on available data and analysis, and should not be considered as financial advice. Investors should conduct their own research and consult with a financial advisor before making any investment decisions.
Data Sources

Popular Stocks